Hemobiotech, Inc. Announces Redemption Of Warrants; HemoBioTech Is Developing HemoTech(TM), A Novel Blood Substitute

DALLAS, June 12 /PRNewswire-FirstCall/ -- HemoBioTech, Inc. (OTC Bulletin Board: HMBT - News) today announced its decision to redeem its outstanding redeemable Class A Warrants. The company issued the warrants in October 2004 in connection with a private placement of its common stock. The company has fixed July 14, 2006 as the date for redemption. The redemption price is $0.001 per share.

Back to news